ES2053679T3 - Embonato de azelastina, procedimiento para su preparacion y preparados farmaceuticos que contienen embonato de azelastina como principio activo. - Google Patents

Embonato de azelastina, procedimiento para su preparacion y preparados farmaceuticos que contienen embonato de azelastina como principio activo.

Info

Publication number
ES2053679T3
ES2053679T3 ES88117969T ES88117969T ES2053679T3 ES 2053679 T3 ES2053679 T3 ES 2053679T3 ES 88117969 T ES88117969 T ES 88117969T ES 88117969 T ES88117969 T ES 88117969T ES 2053679 T3 ES2053679 T3 ES 2053679T3
Authority
ES
Spain
Prior art keywords
embonate
azelastin
procedure
preparation
active substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88117969T
Other languages
English (en)
Inventor
Gerhard Dr Scheffler
Dieter Sauerbier
Jurgen Dr Engel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Asta Medica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica GmbH filed Critical Asta Medica GmbH
Application granted granted Critical
Publication of ES2053679T3 publication Critical patent/ES2053679T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Abstract

EMBONATO DE AZELASTINA Y PREPARADOS FARMACEUTICOS QUE CONTIENEN EMBONATO DE AZELASTINA COMO SUSTANCIA ACTIVA
ES88117969T 1987-11-13 1988-10-28 Embonato de azelastina, procedimiento para su preparacion y preparados farmaceuticos que contienen embonato de azelastina como principio activo. Expired - Lifetime ES2053679T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3738641 1987-11-13
SG153894A SG153894G (en) 1987-11-13 1994-10-21 Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient

Publications (1)

Publication Number Publication Date
ES2053679T3 true ES2053679T3 (es) 1994-08-01

Family

ID=25861795

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88117969T Expired - Lifetime ES2053679T3 (es) 1987-11-13 1988-10-28 Embonato de azelastina, procedimiento para su preparacion y preparados farmaceuticos que contienen embonato de azelastina como principio activo.

Country Status (9)

Country Link
EP (1) EP0316639B1 (es)
JP (1) JP2730581B2 (es)
AT (1) ATE106883T1 (es)
CA (1) CA1317595C (es)
DE (1) DE3850044D1 (es)
DK (1) DK170339B1 (es)
ES (1) ES2053679T3 (es)
HK (1) HK135494A (es)
SG (1) SG153894G (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE107643T1 (de) * 1989-05-05 1994-07-15 Asta Medica Ag Salze des azelastins mit verbesserter löslichkeit.
JPH04198180A (ja) * 1990-11-28 1992-07-17 Eezai Kagaku Kk ベンジルフタラゾン誘導体の製造方法
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
PT2522365T (pt) 2004-11-24 2017-02-08 Meda Pharmaceuticals Inc Composições que compreendem azelastina e seus métodos de utilização
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH572914A5 (es) * 1971-01-22 1976-02-27 Asta Werke Ag Chem Fab

Also Published As

Publication number Publication date
DE3850044D1 (de) 1994-07-14
SG153894G (en) 1995-03-17
DK630088D0 (da) 1988-11-11
JPH01153686A (ja) 1989-06-15
DK630088A (da) 1989-05-14
JP2730581B2 (ja) 1998-03-25
DK170339B1 (da) 1995-08-07
HK135494A (en) 1994-12-09
CA1317595C (en) 1993-05-11
ATE106883T1 (de) 1994-06-15
EP0316639B1 (de) 1994-06-08
EP0316639A2 (de) 1989-05-24
EP0316639A3 (en) 1990-07-18

Similar Documents

Publication Publication Date Title
TR200100366T2 (tr) Aktif madde dağıtmaya mahsus bileşikler ve bileşimler.
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
ES531978A0 (es) Un procedimiento para preparar composiciones farmaceuticas de disolucion rapida que contienen como ingrediente activo triamteremo o metolazona.
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
IL56369A (en) Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
ES2058151T3 (es) Complejos de saponinas con fosfolipidos y composiciones farmaceuticas y cosmeticas que los contienen.
DK605786D0 (da) Stabiliserede human-vaevsplasminogenaktivator-praeparater
AR008991A1 (es) Compuestos de dimetil-(3-aril-but-3-enil)-amina, procedimientos para su preparacion y aplicacion de los mismos
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
DE69716469T2 (de) Pharmazeutische zusammensetzung enthaltend ein osteogenese foerderndes mittel und ein polyethylen-glycol
NO921382D0 (no) Amidinofenylalaninderivater, samt fremstilling, anvendelse og preparater inneholdende forbindelsene
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
ES525574A0 (es) Procedimiento para producir preparaciones farmaceuticas que contienen como substancias activas derivados de polialquilenglicol.
IL139318A (en) Sugar alcohol mixtures as therapeutic agents and pharmaceutical compositions containing the same
ES2053679T3 (es) Embonato de azelastina, procedimiento para su preparacion y preparados farmaceuticos que contienen embonato de azelastina como principio activo.
EP1084710A4 (en) DRUGS AGAINST MALE STERILITY
MX9100441A (es) Procedimiento para fabricar preparados solidos orales,que contienen ifosfamida como agente activo
DK0853476T5 (da) Nimesulidholdigt farmaceutisk præparat til topisk anvendelse
ES2175661T3 (es) Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
DK0521353T3 (da) Lægemiddel med antineoplastisk virkning, der som virksomt stof indeholder octadecyl-(2-(N-metylpiperidino)-ethyl)-phosphat og fremgangsmåde til fremstilling deraf
MX9100886A (es) Activador de plasminogeno hibrido,procedimiento para su preparacion y composiciones farmaceuticas que lo contienen
SE8503447D0 (sv) Farmaceutiska och kosmetiska kompositioner, innehallande dihydroxi-1,8-fenyl-10-antron-9 som verksam bestandsdel, samt sett att framstella den verksamma foreningen
ES2057528T3 (es) Pdgf-a, pdgf-aa, pdgf-ab, procedimientos de preparacion y medicamentos que los contienen.
IE883402L (en) Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 316639

Country of ref document: ES